Pharma MR workflow acceleration
NquiRx gives pharma MR teams and consultancies one operating path from brief intake and draft review to programmed surveys, hosted respondent links, field coordination, and response exports while keeping existing panel partners in the loop.
Study operating path
Existing panel partners stay in the loop.
Team fit
Whether your team manages access, delivery, or the research outcome, NquiRx keeps the study path easier to review, launch, and read out.
Add a higher-value study workflow capability around the respondent access and field execution your clients already rely on.
Consulting teams can accelerate the current study process, reduce manual coordination, and protect expert review time.
Lean biotech and pharma teams can get a more complete MR operating path without taking on the budget impact of a full-service consulting engagement.
Product workflow
A closer look at how NquiRx keeps survey programming, hosted respondent links, vendor coordination, launch tracking, response exports, and early open-end signals moving through one connected study path.
Evaluate blinded oncology HCP concept preference.
US and Germany HCPs, oncology focus.
Stimulus attached, draft screener notes captured.
Launch-ready draft needed this week.
Eligibility, specialty, market, and concept-exposure checks prepared for review.
Profile preference, rationale, and open-end probes organized into a first draft.
Assumptions and open clarifications surfaced before stakeholder review.
Creating review-ready draft...
Oncology HCP concept test
Use blinded product profile wording, keep the attribute order consistent, and apply the update across the master draft and Germany market version.
Reviewing comment and drafting update...
Feasibility questions need an owner-ready follow-up before recruitment can move cleanly.
Can you confirm feasible incidence by market, target completes by Friday, and any exclusions needed for the blinded profile review?
Preparing owner-ready vendor follow-up...
Early comments cluster around access, dosing simplicity, and confidence in the safety profile.
Access and affordability language appears in 9 of 18 comments.
Dosing simplicity is the strongest positive driver.
Safety confidence is a recurring concern to inspect before readout.
Analyzing open-end responses...
Expert-led workflow
NquiRx keeps the operational path cleaner while preserving the judgment, review, respondents, and partner workflows that make pharma MR credible.
Researchers still own methodology, tradeoffs, approvals, and final materials. NquiRx makes the artifact trail easier to inspect.
The workflow is built around real respondent and vendor steps already present in pharma market research.
Review notes, programmed survey links, vendor instructions, field status, and response exports stay attached to one study record.
Book a demo to walk through how NquiRx connects brief, draft, review, survey programming, hosted respondent links, QA, and fieldwork without adding another disconnected layer to manage.
Trust and process fit
Compliance is a shared responsibility; we collaborate with your legal, privacy, and insights teams to fit your requirements.
Operating scope
NquiRx connects the operational materials that otherwise split across documents, trackers, survey links, and vendor emails.
Founder-led demo
Clarify that the profile is blinded and keep the attribute order consistent across markets.